Chen et al. found that SNHG3 is highly expressed in the calcified valves of patients with CAVD and in VICs undergoing osteogenic differentiation, and that SNHG3 expression is positively correlated with CAVD progression (58). This evidence concerns the gene SNHG3 and congenital bilateral aplasia of vas deferens from CFTR mutation.